Internal Medicine, Endocrinology, Diabetes, & Metabolism · Clifton, NJ
NPI
1043637192
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2 Brighton Rd Ste 400
Clifton, NJ, 07012
Phone (862) 297-9696
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,703 services
Medicare patients, 2024
329
Average age 71
Drug cost, 2024
$3.9M
7,904 prescriptions
Company payments, 2025
$1,618
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fadwa Sumrein was code 99214 (office e&m - established), 655 times for 282 patients. In total Fadwa Sumrein billed 1,703 services in 10 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 655 | 282 | $104.62 | $69K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 457 | 240 | $14.75 | $6,740 |
| 82962 Clinical Chemistry | Office | 177 | 109 | $3.10 | $549 |
| 95251 Test - Miscellaneous | Office | 143 | 66 | $28.82 | $4,122 |
| 99232 Hospital E&M - Subsequent | Facility | 128 | 23 | $71.07 | $9,097 |
| 82947 Clinical Chemistry | Office | 64 | 58 | $3.79 | $243 |
| 99204 Office E&M - New | Office | 44 | 44 | $136.25 | $5,995 |
| 99222 Hospital E&M - Initial | Facility | 29 | 28 | $117.55 | $3,409 |
By year: 2022 $84K for 1,223 services; 2023 $85K for 1,174 services; 2024 $99K for 1,703 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 177 | 109 | $3.10 | $549 |
| 82947 Clinical Chemistry | 64 | 58 | $3.79 | $243 |
Medicare prescription drug claims, 2024
In 2024, the drug Fadwa Sumrein prescribed most often to Medicare patients was Ozempic (Semaglutide), with 834 prescriptions and refills. In total Fadwa Sumrein wrote 7,904 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 834 | 1,064 | 160 | $998K |
| Metformin Hcl Generic | 679 | 1,737 | 223 | $4,840 |
| Jardiance Empagliflozin | 601 | 1,054 | 127 | $609K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 505 | 914 | 138 | $61K |
| Levothyroxine Sodium Generic | 474 | 1,267 | 150 | $4,255 |
| Trulicity Dulaglutide | 468 | 545 | 81 | $513K |
| Mounjaro Tirzepatide | 327 | 374 | 63 | $386K |
| Farxiga Dapagliflozin Propanediol | 290 | 536 | 76 | $297K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 267 | 474 | 99 | $19K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 210 | 337 | 55 | $81K |
| Atorvastatin Calcium Generic | 156 | 372 | 52 | $1,270 |
| Repaglinide Generic | 145 | 255 | 37 | $2,842 |
| Humalog Kwikpen U-100 Insulin Lispro | 139 | 244 | 43 | $28K |
| Pioglitazone Hcl Generic | 134 | 242 | 39 | $1,014 |
| Metformin Hcl Er Metformin Hcl | 115 | 251 | 34 | $829 |
Brand drugs: 4,650 claims; generic drugs: 2,434 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fadwa Sumrein $1,618 ($1,618 in general payments such as food, travel and fees) from 20 companies. The largest payer was Medtronic, Inc. with $801.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 5 | $801 |
| Novo Nordisk Inc NVO | 16 | $201 |
| Amgen Inc. AMGN | 9 | $138 |
| Abbvie Inc. ABBV | 4 | $66.9 |
| Xeris Pharmaceuticals, Inc. | 3 | $53.65 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $50.69 |
| Abbott Laboratories ABT | 2 | $46.57 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $36.41 |
| Lilly USA, LLC LLY | 2 | $30.21 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $25.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.